Rhinophototherapy in chronic rhinosinusitis: a double blind randomized placebo-controlled trial.

Related Articles

Rhinophototherapy in chronic rhinosinusitis: a double blind randomized placebo-controlled trial.

Rhinology. 2017 May 14;:

Authors: Dulguerov N, Guinand N, Courvoisier D, Landis BN, Lacroix JS, Hauser C

Abstract
BACKGROUND: This study evaluated the efficacy of rhinophototherapy in patients with chronic rhinosinusitis (CRS) without nasal polyps.
METHOD: In this randomized double-blind, placebo-controlled trial, CRS patients (n=50) received either mixed visible and ultraviolet (UVA and UVB) light source application (mUV/VIS) or visible light alone that served as placebo. Both groups were treated for 3 weeks.
RESULTS: Results in the rhinophototherapy and placebo group were not significantly different and failed to reduce patient-reported outcomes measures (Rhinosinusits Disability Index, Visual Analogic Scale of symptom severity) and objective scores (rhinomanometry, olfactory thresholds, nasal Nitic Oxide concentrations), immediately and one month after treatment.
CONCLUSIONS: The present data suggest that rhinophototherapy is not an efficient treatment for chronic rhinosinusitis without nasal polyps.

PMID: 28501886 [PubMed - as supplied by publisher]

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2pD4Ysf
via IFTTT